Healio4d
Phase 2 Osprey, Apteryx studies of QLS-111 meet all endpoints
Patients with primary open-angle glaucoma or ocular hypertension achieved lower IOP. All concentrations of QLS-111 were safe and well tolerated. Patients with primary open-angle glaucoma or ocular ...
Crain's Detroit4d
Supplier sues Stellantis in another money dispute for the automaker
Safariland LLC, which makes tire covers and emergency roadside kits for the carmaker, on Dec. 20 filed a complaint in which it claims Stellantis owes $1.2 million in unpaid invoices, according to ...
clinicaltrialsarena3d
Qlaris Bio’s QLS 111 therapy shows positive outcomes in Phase II trials
Credit: YAKOBCHUK VIACHESLAV/Shutterstock. Qlaris Bio has reported positive topline outcomes from two randomised Phase II US trials, Osprey and Apteryx, of QLS 111 in individuals with primary ...
BioSpace4d
Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
QLS-111 added to latanoprost drove up to 3.6 mmHg greater reduction in IOP as compared to latanoprost alone DEDHAM, Mass.--(BUSINESS WIRE)--Qlaris Bio, Inc., a clinical-stage biotechnology company ...